0 01/02/2025 31/01/2026 2026-01-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2025-02-01 Sage Accounts Production 25.0 - FRS102_2025 xbrli:pure xbrli:shares iso4217:GBP 12394752 2025-02-01 2026-01-31 12394752 2026-01-31 12394752 2025-01-31 12394752 2024-02-01 2025-01-31 12394752 2025-01-31 12394752 2024-01-31 12394752 bus:Director1 2025-02-01 2026-01-31 12394752 core:WithinOneYear 2026-01-31 12394752 core:WithinOneYear 2025-01-31 12394752 bus:Director1 2025-01-31 12394752 bus:Director1 2026-01-31 12394752 bus:Director1 2024-01-31 12394752 bus:Director1 2025-01-31 12394752 bus:Director1 2024-02-01 2025-01-31 12394752 bus:Micro-entities 2025-02-01 2026-01-31 12394752 bus:AuditExempt-NoAccountantsReport 2025-02-01 2026-01-31 12394752 bus:SmallCompaniesRegimeForAccounts 2025-02-01 2026-01-31 12394752 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 12394752 bus:FullAccounts 2025-02-01 2026-01-31
Company registration number: 12394752
Aspirica Limited
Unaudited filleted financial statements
31 January 2026
Aspirica Limited
Contents
Statement of financial position and notes to the financial statements
Aspirica Limited
Statement of financial position
31 January 2026
2026 2025
£ £
Fixed assets 6,184 6,259
_______ _______
Current assets 154,738 110,701
Creditors: amounts falling due within one year ( 52,240) ( 37,670)
_______ _______
Net current assets 102,498 73,031
_______ _______
Total assets less current liabilities 108,682 79,290
Accruals and deferred income ( 1,630) ( 1,563)
_______ _______
Net assets 107,052 77,727
_______ _______
Capital and reserves 107,052 77,727
_______ _______
Notes to the financial statements
Aspirica Limited
Year ended 31 January 2026
1. Employee numbers
The average number of persons employed by the company during the year amounted to Nil (2025: 1 ).
2. Directors advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2026
Balance brought forward Advances /(credits) to the director Amounts repaid Balance o/standing
£ £ £ £
G Rooney 98,980 154,758 ( 99,000) 154,738
_______ _______ _______ _______
2025
Balance brought forward Advances /(credits) to the director Amounts repaid Balance o/standing
£ £ £ £
G Rooney 143,100 98,980 ( 143,100) 98,980
_______ _______ _______ _______
The directors loan balance was paid within 9 months of the year end by the way of dividend.
For the year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The member has not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The director acknowledges responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 24 September 2026 , and are signed on behalf of the board by:
G Rooney
Director
Company registration number: 12394752
The company is a private company limited by shares, registered in England & Wales. The address of the registered office is 9 Higher Lydgate Park, Grasscroft, Oldham, OL4 4EF.